Evidence map›Paper›PMID 32838194›Full record

ArticleSN comprehensive clinical medicine2020

Factors Affecting Mortality in 1022 COVID-19 Patients Referred to an Emergency Department in Bergamo during the Peak of the Pandemic.

Orlando Goletti, Chiara Nessi, Amidio Testa, Giovanni Albano, Valter Torri, Giordano Domenico Beretta, Massimo Castoldi, Emilio Bombardieri

Abstract read
In one paragraph

Article in SN comprehensive clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Orlando GolettiGeneral Surgery Unit, Humanitas Gavazzeni, Bergamo, Italy.
Chiara NessiSchool of Specialization of General Surgery, University of Verona, Verona, Italy.
Amidio TestaInternal Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy.
Giovanni AlbanoAnesthesia and Intensive Care Unit, Humanitas Gavazzeni, Bergamo, Italy.
Valter TorriClinical Research Methodology Laboratory, Oncology Unit, IRCCS, Mario Negri Institute, Milan, Italy.
Giordano Domenico BerettaMedical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy.
Massimo CastoldiMedical Direction, Humanitas Gavazzeni, Bergamo, Italy.
Emilio BombardieriScientific Direction, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0003-4063-8167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unexpected outbreak of COVID-19 in the area of Bergamo and the general crisis of personnel and devices has been managed as well as possible during the maximum peak of epidemic; Humanitas Gavazzeni Hospital implemented its facilities and organization in order to optimize the treatment of patients. The number of beds in the Intensive Care Unit (ICU) was doubled (from 16 to 33), and more than 220 beds were dedicated to the COVID-19 patients. This paper analyzes the factors affecting mortality in 1022 COVID-19 patients who referred to Humanitas Gavazzeni between February 25 and March 26, 2020. A total of 274 (34.9%) fatal events were registered: 202 among those admitted to the Intensive Care Unit (ICU) and COVID department and 72 among those treated in Acute Admission Unit Level II (AAUl-2) who died before hospital admission. This paper studies 274 dead cases by analyzing patient's characteristics, physiological and laboratory parameters, symptoms, and the scores of severity of the disease. Patients who had fatal events in the AAUL-2 showed the worst parameters of risk. The most important differences regarded the Apache II score, Glasgow Coma Score (GCS), CRP (C-reactive protein), pH, creatinine, RR (respiratory rate), and asthenia.

Indexed as

COVID-19 mortalityEmergency during the peak of infectionRisk factorsSeverity

Identifiers

PMID32838194
PMCPMC7430544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.